Fidelity Advisor Biotechnology Fund Quote
| FBTTX Fund | USD 24.94 0.22 0.89% |
PerformanceVery Weak
| Odds Of DistressLow
|
Fidelity Advisor is trading at 24.94 as of the 25th of March 2025; that is 0.89 percent up since the beginning of the trading day. The fund's open price was 24.72. Fidelity Advisor has about a 21 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 25th of December 2024 and ending today, the 25th of March 2025. Click here to learn more.
The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes, and companies that benefit significantly from scientific and technological advances in biotechnology. More on Fidelity Advisor Biotechnology
Fidelity Mutual Fund Highlights
| Thematic Idea | Monster Funds (View all Themes) |
| Fund Concentration | Fidelity Investments Funds, Large Funds, Health Funds, Monster Funds, Health, Fidelity Investments, Large, Health (View all Sectors) |
| Update Date | 31st of March 2025 |
Fidelity Advisor Biotechnology [FBTTX] is traded in USA and was established 25th of March 2025. Fidelity Advisor is listed under Fidelity Investments category by Fama And French industry classification. The fund is listed under Health category and is part of Fidelity Investments family. The entity is thematically classified as Monster Funds. This fund currently has accumulated 2.85 B in assets under management (AUM) with no minimum investment requirementsFidelity Advisor Bio is currently producing year-to-date (YTD) return of 0.2% with the current yeild of 0.03%, while the total return for the last 3 years was 5.72%.
Check Fidelity Advisor Probability Of Bankruptcy
Instrument Allocation
Top Fidelity Advisor Biotechnology Mutual Fund Constituents
| AGIO | Agios Pharm | Stock | Health Care | |
| ALNY | Alnylam Pharmaceuticals | Stock | Health Care | |
| BPMC | Blueprint Medicines Corp | Stock | Health Care | |
| ABBV | AbbVie Inc | Stock | Health Care | |
| INCY | Incyte | Stock | Health Care | |
| VRTX | Vertex Pharmaceuticals | Stock | Health Care | |
| SAGE | Sage Therapeutic | Stock | Health Care | |
| BIIB | Biogen Inc | Stock | Health Care |
Fidelity Advisor Bio Risk Profiles
Fidelity Advisor Against Markets
Other Information on Investing in Fidelity Mutual Fund
Fidelity Advisor financial ratios help investors to determine whether Fidelity Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fidelity with respect to the benefits of owning Fidelity Advisor security.
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |